Department of Laboratory Medicine, Affiliated Hospital of Jiangnan University, Wuxi, China.
Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Front Immunol. 2019 Dec 13;10:2918. doi: 10.3389/fimmu.2019.02918. eCollection 2019.
For many decades, T helper 2 (T2) cells have been considered to predominantly regulate the pathogenic manifestations of allergic asthma, such as IgE-mediated sensitization, airway hyperresponsiveness, and eosinophil infiltration. However, recent discoveries have significantly shifted our understanding of asthma from a simple T2 cell-dependent disease to a heterogeneous disease regulated by multiple T cell subsets, including T follicular helper (T) cells. T cells, which are a specialized cell population that provides help to B cells, have attracted intensive attention in the past decade because of their crucial role in regulating antibody response in a broad range of diseases. In particular, T cells are essential for IgE antibody class-switching. In this review, we summarize the recent progress regarding the role of T cells and their signature cytokine interleukin (IL)-21 in asthma from mouse studies and clinical reports. We further discuss future therapeutic strategies to treat asthma by targeting T cells and IL-21.
几十年来,辅助性 T 细胞 2(T2)细胞一直被认为主要调节过敏性哮喘的发病表现,如 IgE 介导的致敏、气道高反应性和嗜酸性粒细胞浸润。然而,最近的发现极大地改变了我们对哮喘的理解,从一种简单的 T2 细胞依赖性疾病转变为一种由多种 T 细胞亚群调节的异质性疾病,包括滤泡辅助性 T(Tfh)细胞。T 细胞是一种提供 B 细胞帮助的特殊细胞群体,由于其在广泛的疾病中调节抗体反应的关键作用,在过去十年中引起了广泛关注。特别是,T 细胞对于 IgE 抗体类别转换至关重要。在这篇综述中,我们总结了关于 T 细胞及其标志性细胞因子白细胞介素(IL)-21 在哮喘中的作用的最新研究进展,包括来自小鼠研究和临床报告的研究进展。我们进一步讨论了通过靶向 T 细胞和 IL-21 治疗哮喘的未来治疗策略。